Secondary Cytoreduction and Perioperative Intraperitoneal Chemotherapy after Initial Debulking of Pseudomyxoma Peritonei: A Study of Timing and the Impact of Malignant Dedifferentiation-Reference-Cited by-同舟云学术

Secondary Cytoreduction and Perioperative Intraperitoneal Chemotherapy after Initial Debulking of Pseudomyxoma Peritonei: A Study of Timing and the Impact of Malignant Dedifferentiation

Published:2010-10 Issue:4 Volume:211 Page:526-535
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:Journal of the American College of Surgeons

Author:

Chua Terence C.,Al-Zahrani Abdulaziz,Saxena Akshat,Liauw Winston,Zhao Jing,Morris David L.

Publisher

Elsevier BV

Subject

Surgery

Reference20 articles.

1. The etiology, clinical presentation, and management of pseudomyxoma peritonei;Moran;Surg Oncol Clin North Am,2003

2. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis;Ronnett;Am J Surg Pathol,1995

3. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms;Yan;Br J Surg,2006

4. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC);Baratti;Ann Surg Oncol,2008

5. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis;Ronnett;Cancer,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival;Cancers;2022-09-13

2. Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis;International Journal of Hyperthermia;2022-08-21

3. Evidence-Based Strategies for the Treatment of Peritoneal Malignancies during Health Care Resource Restriction: The COVID-19 Pandemic;Current Oncology;2020-12-01

4. Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept;International Journal of Hyperthermia;2020-01-01

5. Early recurrence in peritoneal metastasis of appendiceal neoplasm: Survival and prognostic factors;European Journal of Surgical Oncology;2019-12